SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
37.72
+1.26 (3.46%)
At close: Jul 19, 2024, 4:00 PM
37.00
-0.72 (-1.91%)
Pre-market: Jul 22, 2024, 7:37 AM EDT

SpringWorks Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Revenue
26.455.4500350
Upgrade
Cost of Revenue
1.620.420000
Upgrade
Gross Profit
24.835.0300350
Upgrade
Selling, General & Admin
213.49197.55134.5571.7929.4716.69
Upgrade
Research & Development
170.59150.49146.12101.6851.8642.55
Upgrade
Operating Expenses
384.07348.04280.67173.4781.3259.24
Upgrade
Operating Income
-359.25-343.01-280.67-173.47-46.32-59.24
Upgrade
Other Expense / Income
-20.18-17.91-3.260.44-0.75-0.93
Upgrade
Pretax Income
-339.07-325.1-277.42-173.91-45.57-58.31
Upgrade
Net Income
-339.07-325.1-277.42-173.91-45.57-58.31
Upgrade
Preferred Dividends
00000-7.73
Upgrade
Net Income Common
-339.07-325.1-277.42-173.91-45.57-50.58
Upgrade
Shares Outstanding (Basic)
746353484313
Upgrade
Shares Outstanding (Diluted)
746353484313
Upgrade
Shares Change
18.36%18.45%9.88%12.00%226.18%3792.75%
Upgrade
EPS (Basic)
-5.15-5.15-5.21-3.59-1.05-3.81
Upgrade
EPS (Diluted)
-5.15-5.15-5.21-3.59-1.05-3.81
Upgrade
Free Cash Flow
-244.89-230.18-171.76-129.89-32.83-48.11
Upgrade
Free Cash Flow Per Share
-3.32-3.65-3.22-2.68-0.76-3.62
Upgrade
Gross Margin
93.86%92.25%--100.00%-
Upgrade
Operating Margin
-1358.05%-6297.28%---132.35%-
Upgrade
Profit Margin
-1281.78%-5968.50%---130.21%-
Upgrade
Free Cash Flow Margin
-925.76%-4225.81%---93.81%-
Upgrade
EBITDA
-335.16-321.78-275.52-172.43-44.18-58.11
Upgrade
EBITDA Margin
-1267.00%-5907.55%---126.22%-
Upgrade
Depreciation & Amortization
3.913.321.91.481.40.19
Upgrade
EBIT
-339.07-325.1-277.42-173.91-45.57-58.31
Upgrade
EBIT Margin
-1281.78%-5968.50%---130.21%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).